News

Eli Lilly looks to end selloff as Goldman upgrades on attractive entry point
Eli Lilly (LLY) stock gains as Goldman Sachs upgrades it to Buy from Neutral citing the company's leadership position in the ...
Zacks Investment Research on MSN13h
LLY vs. NVO: Which Weight-Loss Drug Stock is a Stronger Play Now?
Novo Nordisk NVO and Eli Lilly LLY dominate the diabetes and obesity market on the back of the tremendous success of their ...
Jim Cramer on Eli Lilly and Company (LLY): “You Don’t Sell Lilly” — “David Ricks Is a Visionary”
We recently published a list of Jim Cramer Nailed These 11 Stock Picks. In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other stocks that Jim ...